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Background
As treatment options in juvenile idiopathic arthritis
(JIA) are quickly developing, limited data exist that
appear fully applicable for informing our newly diag-
nosed JIA patients about the expected course of their
disease
Aim
To evaluate disease course and outcome of patients in
the first two years after diagnosis JIA when treated
according to local standard of clinical care.
Methods
We performed a retrospective inception cohort study of
children with JIA, diagnosed between 2003 and 2007,
treated in referral centers in Amsterdam. Disease status
was determined for every outpatient clinic visit. Data
regarding medication, functional outcome and radiogra-
phy were recorded.
Results
149 consecutive newly diagnosed JIA patients were
included. Median age at diagnosis was 11.8 years with a
median follow up of 33 months. DMARDs were used in
95% of the patients including methotrexate in 85%, sul-
fasalazine in 41% and biologicals in 20%. DMARDs were
started within median one month after diagnosis. Dur-
ing follow-up 77% of patients achieved a total of 244
episodes of inactive disease (ID). ID was reached after
median 10 months. After 2 years a median CHAQ score
of 0.6 was reported. Radiological joint damage occurred
at some point in 12% of patients: 3% showed damage at
diagnosis and another 9% developed joint damage within
a median of 20 months after their first clinic visit.
Conclusions
With current management strategies in daily clinical
practice, 77% of newly diagnosed JIA patients achieve a
first episode of inactive disease within a median of 10
months. After 2 years, patients report a moderate func-
tional disability and more than 10% show radiological
evidence of joint damage.
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